NEW YORK, Feb. 23 (GenomeWeb News) - Bruker BioSciences yesterday reported fourth quarter 2005 revenues of $80.6 million, down from $85.6 million in the fourth quarter of 2004.
Revenues increased by 1 percent when adjusted for foreign currency effects, the company said.
Bruker reported net income of $1.9 million for the period ended Dec. 31, compared to a loss of $900,000 in the year-ago period.
R&D expenses dropped to $9.4 million in the current quarter, versus $12.1 million in the similar quarter last year.
The company had around $99.7 million in cash and short-term investments as of Dec. 31.